Rifadin is a brand name of rifampin, approved by the FDA in the following formulation(s):
RIFADIN (rifampin - capsule; oral)
Manufacturer: SANOFI AVENTIS US
Approved Prior to Jan 1, 1982
Strength(s): 300MG [RLD][AB]
RIFADIN (rifampin - injectable; injection)
Manufacturer: SANOFI AVENTIS US
Approval date: May 25, 1989
Strength(s): 600MG/VIAL [RLD][AP]
Has a generic version of Rifadin been approved?
Yes. The following products are equivalent to Rifadin:
rifampin capsule; oral
Manufacturer: LANNETT
Approval date: March 28, 2008
Strength(s): 300MG [AB]
Manufacturer: SANDOZ
Approval date: May 28, 1997
Strength(s): 300MG [AB]
Manufacturer: VERSAPHARM
Approval date: March 14, 2001
Strength(s): 300MG [AB]
rifampin injectable; injection
Manufacturer: BEDFORD
Approval date: October 29, 1999
Strength(s): 600MG/VIAL [AP]
Manufacturer: PFIZER
Approval date: May 22, 2008
Strength(s): 600MG/VIAL [AP]
Manufacturer: VERSAPHARM INC
Approval date: September 21, 2010
Strength(s): 600MG/VIAL [AP]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Rifadin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
There are no current U.S. patents associated with Rifadin.
See also...
- Rifadin Consumer Information (Wolters Kluwer)
- Rifadin Consumer Information (Cerner Multum)
- Rifadin Advanced Consumer Information (Micromedex)
- Rifampin Consumer Information (Wolters Kluwer)
- Rifampin Capsules Consumer Information (Wolters Kluwer)
- Rifampin Consumer Information (Cerner Multum)
- Rifampin Intravenous Advanced Consumer Information (Micromedex)
- Rifampin Oral, Intravenous Advanced Consumer Information (Micromedex)
- Rifampin AHFS DI Monographs (ASHP)
No comments:
Post a Comment